Reported 2 days ago
Jim Cramer hailed Eli Lilly and Company (LLY) as a ‘game changer’ following the successful results of its obesity pill trial. Cramer emphasized the importance of transitioning from injections to pills to meet consumer preference, citing studies revealing that a significant majority of potential users prefer oral medication. He noted that Eli Lilly is well-prepared with substantial manufacturing capabilities, indicating a promising future for the pharmaceutical company and its weight loss treatments.
Source: YAHOO